Introduction
Cytochrome P450 (CYP) is a superfamily of hemoproteins, many of which can metabolize xenobiotics such as procarcinogens, drugs and environmental pollutants. CYP2A6 is a major hepatic member of the family which metabolizes pharmaceutical agents such as coumarin and activates some procarcinogens, including 4-methylnitrosoamino-1-(3-pyridyl)-1-butanone and N-nitrosodiethylamine (1, 2) . CYP2A6 also metabolizes nicotine to cotinine via C-oxidation (3) (4) (5) . It was previously reported that subjects with a CYP2A6 homozygous gene deletion had significantly impaired nicotine metabolism (6, 7) . In addition to a deletion type allele (CYP2A6*4), three more genetic polymorphisms of CYP2A6, CYP2A6*2, *3 and *5, were reported to result in enzymatic inactivation (8) (9) (10) . This genetic polymorphism of CYP2A6 is suspected to be a major cause of interindividual variation in enzymatic activity for various CYP2A6 substrates, and it is thereby critical to characterize the enzymatic properties caused by the polymorphism.
In our previous work characterizing the CYP2A6 genotypes among 252 Japanese subjects, a new variant was detected (6) . In the present study, this novel variant was more extensively studied using the PCR technology combined with restriction enzyme fragment length
7
For the alignment study, amino acid sequences of CYP2 family were referenced from online information (Human Cytochrome P450 Allele Nomenclature Committee).
Construction of expression plasmids and the Baculovirus expression system
The full-length CYP2A6*1 cDNA, in PUC18 (a kind gift from F.J. Gonzalez) was digested with EcoRI and SalI and subcloned into the EcoRI and XhoI sites of pBacPAK9 (Clontech). CYP2A6*6 cDNA was generated by PCR using high fidelity thermostable DNA polymerase KOD (Toyobo).
Three kinds of pBacPAK9 vectors, without CYP2A6 (negative control), with CYP2A6*1, or with CYP2A6*6 cDNA, were transfected into Sf9 cells to obtain recombinant baculoviruses.
Hemin (Sigma) was added to the culture medium of Sf9 cells at a final concentration of 4 mg/ml 24 hours after infection with baculoviruses. After incubation for 48 hours, the cells were harvested, washed with PBS(-) and stored at -80 o C until each analysis.
8 applied a horseradish peroxidase-conjugated anti-mouse IgG polyclonal preparation (Promega), and then proceeded for visualization using an enhanced chemiluminescence system (NEN).
Two and one-half micrograms of commercially available cell lysate containing recombinant CYP2A6 (Gentest) was used as a positive control.
Coumarin 7-hydroxylase activity
Coumarin 7-hydroxylase activity was measured in 125 ml reaction mixtures comprising 50 mg of lysate protein, 1.3 mM NADP + (Sigma), 3.3 mM glucose-6-phosphate (Sigma), 0.4 U/ml glucose-6-phosphate dehydrogenase (Sigma), 3.3 mM magnesium chloride, 23 nmol P450 reductase (Gentest), 0.93 mg cytochrome b5 (Panvera), and 0.4 mM coumarin (Nakarai) in 50 mM Tris (pH 7.4). After incubation at 37 o C for 20 min, the reaction was stopped by the addition of 50 ml of 20% trichloroacetic acid followed by centrifugation at 10,000 g for 5 min. Fifty microliters of the supernatant fraction was diluted with 950 ml of 100 mM Tris (pH 9.0) and the fluorescence was determined at wavelengths of 368 nm for excitation and 456 nm for emission using a Hitachi F4010 fluorescence spectrophotometer.
was removed by centrifugation at 10,000 g for 10 min at 4 o C. The soluble fraction was then divided into reference and sample cuvettes, CO was gently bubbled into the sample cuvette for 30 sec, and sodium dithionite (Wako) was dissolved in both cuvettes. CO difference spectra were recorded using a Beckman DU70 spectrophotometer.
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Results
Genotyping of CYP2A6 and sequencing of novel variants
CYP2A6 genotyping by PCR-RFLP was carried out for 894 healthy Japanese subjects.
A homozygous deletion was found in 3.7% of subjects, however, no individual with either CYP2A6*2 or CYP2A6*3 was detected. These findings were consistent with those of a previous study (16) . Six subjects showed two kinds of unknown enzyme digestion patterns.
Four individuals (0.4%) showed a single MspI digestion-site heterozygosity, and the other two (0.2%) showed a single DdeI recognition-site heterozygosity ( Fig. 1 , A and C). The PCR products from these individuals were subcloned, sequenced from exon 3, and compared with CYP2A6*1 (Fig. 1B) . The difference found in those individuals was one of two single nucleotide substitutions, either G to A at 383 or C to A at 406, resulting in amino acid substitution R128Q
(CGG to CAG) or a silent mutation at R136 (CGG to AGG), respectively ( Table I ). This R128Q polymorphism was designated CYP2A6*6.
The P450 superfamily has highly conserved structural elements including the A to Lhelices (Fig. 1D) . The positively charged arginine residue at 128 in the C-helix is especially highly conserved (11, 17, 18) . Since glutamine is either neutral or weakly basic, it is suspected that this substitution of R128Q would probably not retain the native structure or enzymatic activity of CYP2A6.
To carry out further analysis of the CYP2A6.6 protein, a recombinant version of CYP2A6.1 was expressed in insect cells using a baculovirus system.
Preparation of recombinant CYP2A6 proteins
The expression of CYP2A6 in Sf9 cells was confirmed by immunoblot analysis using a monoclonal CYP2A6 antibody. A single band of the same size as commercially available CYP2A6
was detected in lysates of both CYP2A6.1-and CYP2A6.6-expressing cells, whereas no such band was detected in the lysate from cells infected with empty virus (Fig. 2A) . The band size was consistent with the molecular weight of CYP2A6, 56.5 kDa. These results showed minimum endogenous production of CYP2A6 in Sf9 cells. The same band was also detected when CYP2A6.1 was expressed in Sf9 cells without exogenously added hemin, indicating that the presence or absence of hemin in the culture medium did not influence the level of CYP2A6
expression. The level of each CYP2A6 apoprotein in 0.4 mg of the positive lysate was higher than that in 2.5 mg of commercially available lysate. These results indicate that all recombinant CYP2A6
constructs were expressed efficiently, resulting in similar levels of CYP2A6 apoprotein content.
Discussion
Mammalian P450s contain a noncovalently bound heme (protoporphyrin IX), the absence of which results in the loss of enzymatic activity. Catalytically active cytochrome P450
can be expressed at a high level using baculovirus when hemin is added to the culture medium during the course of viral infection. This requirement for exogenous hemin may be due to the From the alignment analysis of the P450 superfamily, it has been determined that the arginine residue R128 of CYP2A6 is highly conserved. Lewis et al. reported that the function of this residue was suspected to be formation of a catalytically essential salt binding site with a heme propionate moiety and cytochrome b5 in P450 cam , which was critical to catalytic activity (12) .
CYP2A7, which is catalytically inactive, shares 94% amino acid sequence identity with CYP2A6.1, and has 38 amino acid substitutions out of a total of 494 residues, including a leucine Coumarin is detoxified by 7-hydroxylation in individuals who have CYP2A6*1. However, coumarin metabolism is altered to 3-hydroxylation in CYP2A6*2 homozygotes, as evidenced by the greatly enhanced excretion of 2-hydroxyphenylacetic acid (28, 29).
2-
Hydroxyphenylacetaldehyde, an intermediate metabolite of coumarin to 2-hydroxyphenylacetic acid, can covalently bind microsomal proteins and cause hepatotoxicity in experimental animals (30). Since CYP2A6 is involved in the metabolism of some toxic substrates, as mentioned above, it is suggested that individuals who are CYP2A6*6 heterozygotes may have altered sodium dithionite was dissolved in both cuvettes. The difference spectrum was recorded using a spectrophotometer. 
